Clinical trial
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Continued Access
NCT01639495 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Continued Access
- Lead sponsor
- Biosense Webster, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 1, 2012
- Completion date
- October 1, 2014
- Enrollment
- 148 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
drug refractory symptomatic paroxysmal atrial fibrillation